These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Improving the Food and Drug Administration's mandate to ensure postmarketing drug safety. Qato DM; Alexander GC JAMA; 2011 Oct; 306(14):1595-6. PubMed ID: 21990303 [No Abstract] [Full Text] [Related]
43. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis. Haymore BR; Yoon J; Mikita CP; Klote MM; DeZee KJ Ann Allergy Asthma Immunol; 2008 Nov; 101(5):495-9. PubMed ID: 19055203 [TBL] [Abstract][Full Text] [Related]
44. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor]. Fast S; Henningsen E; Bygum A Ugeskr Laeger; 2011 Oct; 173(41):2574-5. PubMed ID: 21985837 [TBL] [Abstract][Full Text] [Related]
45. Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System. Chrischilles EA; Gagne JJ; Fireman B; Nelson J; Toh S; Shoaibi A; Reichman ME; Wang S; Nguyen M; Zhang R; Izem R; Goulding MR; Southworth MR; Graham DJ; Fuller C; Katcoff H; Woodworth T; Rogers C; Saliga R; Lin ND; McMahill-Walraven CN; Nair VP; Haynes K; Carnahan RM Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):263-271. PubMed ID: 29318683 [TBL] [Abstract][Full Text] [Related]
46. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant. Schmidt PW; Hirschl MM; Trautinger F J Am Acad Dermatol; 2010 Nov; 63(5):913-4. PubMed ID: 20554347 [No Abstract] [Full Text] [Related]
49. Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neglected issue in daily practice in Greece. Symvoulakis EK; Kyrmizakis DE; Drivas EI; Bizakis J; Velegrakis GA; Lionis C Eur J Gen Pract; 2007; 13(4):239-41. PubMed ID: 18324507 [TBL] [Abstract][Full Text] [Related]
50. Angioedema likely related to angiotensin converting enzyme inhibitors. Matsumura M; Haruki K; Kajinami K; Takada T Intern Med; 1993 May; 32(5):424-6. PubMed ID: 8400508 [TBL] [Abstract][Full Text] [Related]
51. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. Morimoto T; Gandhi TK; Fiskio JM; Seger AC; So JW; Cook EF; Fukui T; Bates DW J Eval Clin Pract; 2004 Nov; 10(4):499-509. PubMed ID: 15482412 [TBL] [Abstract][Full Text] [Related]
52. The Devil's in the details: Reports on reproducibility in pharmacoepidemiologic studies. Petrone AB; DuCott A; Gagne JJ; Toh S; Maro JC Pharmacoepidemiol Drug Saf; 2019 May; 28(5):671-679. PubMed ID: 30843303 [TBL] [Abstract][Full Text] [Related]
53. [Life-threatening angioedema as a side effect of angiotensin-converting-enzyme (ACE) inhibitors]. Bauwens LJ; Copper MP; Schmidt JT Ned Tijdschr Geneeskd; 1995 Apr; 139(13):674-7. PubMed ID: 7723869 [TBL] [Abstract][Full Text] [Related]
54. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project. Bandak G; Sang Y; Gasparini A; Chang AR; Ballew SH; Evans M; Arnlov J; Lund LH; Inker LA; Coresh J; Carrero JJ; Grams ME J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724651 [TBL] [Abstract][Full Text] [Related]
58. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. Beavers CJ; Dunn SP; Macaulay TE Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294 [TBL] [Abstract][Full Text] [Related]
59. [Angioedema and angiotensin converting enzyme inhibitors: a report of 19 cases]. Ducroix JP; Outurquin S; Benabes-Jezraoui B; Gras V; Chaby G; Strunski V; Salle V; Smail A; Lok C; Andrejak M Rev Med Interne; 2004 Jul; 25(7):501-6. PubMed ID: 15219368 [TBL] [Abstract][Full Text] [Related]
60. Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic. Roberts JR; Lee JJ; Marthers DA Am J Cardiol; 2012 Mar; 109(5):774-5. PubMed ID: 22364704 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]